Syndromic diagnostic testing: a new way to approach patient care in the treatment of infectious diseases
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Advanced microbiology technologies such as multiplex molecular assays (i.e. syndromic diagnostic tests) are a novel approach to the rapid diagnosis of common infectious diseases. As the global burden of antimicrobial resistance continues to rise, the judicious use of antimicrobials is of utmost importance. Syndromic panels are now being recognized in some clinical practice guidelines as a ‘game-changer’ in the diagnosis of infectious diseases. These syndromic panels, if implemented thoughtfully and interpreted carefully, have the potential to improve patient outcomes through improved clinical decision making, optimized laboratory workflow, and enhanced antimicrobial stewardship. This paper reviews the potential benefits of and considerations regarding various infectious diseases syndromic panels, and highlights how to maximize impact through collaboration between clinical microbiology laboratory and antimicrobial stewardship programmes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to conventional methods, they provide several advantages: faster turnaround time, broader coverage, and reliable performance even in patients who have already received empirical antimicrobial treatment, which often reduces culture sensitivity.3,4”
From Utility and clinical relevance of multiplex PCR panels for diagnosis of central nervous system infections (2026) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
Leber, A. L., Everhart, K., Balada-Llasat, J.-M., Cullison, J., Daly, J., Holt, S., Lephart, P., Salimnia, H., Schreckenberger, P. C., DesJarlais, S., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00730-16 · Cited by 609
Banerjee, R., Teng, C. B., Cunningham, S. A., Ihde, S. M., Steckelberg, J. M., Moriarty, J. P., Shah, N. D., Mandrekar, J. N., & Patel, R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ447 · Cited by 570
Molecular Detection of Antimicrobial Resistance
Fluit, A. C., Visser, M. R., & Schmitz, F.-J. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.836-871.2001 · Cited by 525
Critical analysis of antibacterial agents in clinical development
Theuretzbacher, U., Bush, K., Harbarth, S., Paul, M., Rex, J. H., Tacconelli, E., & Thwaites, G. E. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0340-0 · Cited by 373
Syndromic Panel-Based Testing in Clinical Microbiology
Ramanan, P., Bryson, A. L., Binnicker, M. J., Pritt, B. S., & Patel, R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00024-17 · Cited by 308
Emerging Technologies for the Clinical Microbiology Laboratory
Buchan, B. W., & Ledeboer, N. A. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00003-14 · Cited by 297
Buchan, B. W., Windham, S., Balada-Llasat, J.-M., Leber, A., Harrington, A., Relich, R., Murphy, C., Dien Bard, J., Naccache, S., Ronen, S., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00135-20 · Cited by 275
Impact of a Rapid Respiratory Panel Test on Patient Outcomes
Rogers, B. B., Shankar, P., Jerris, R. C., Kotzbauer, D., Anderson, E. J., Watson, J. R., O'Brien, L. A., Uwindatwa, F., McNamara, K., & Bost, J. E. (2015) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0257-oa · Cited by 251
Popowitch, E. B., O'Neill, S. S., & Miller, M. B. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.03368-12 · Cited by 249
Cited by
Gürler, M., Karaoğlu, Ç., Yurtcu, E. E., Us, E., & Karahan, Z. C. (2026) · The Indian Journal of Medical Research · doi:10.25259/ijmr_2107_2025
“3,4 Despite their benefits, multiplex panels are not without limitations.”
Metadata
- Authors
- Dumkow, L. E., Worden, L. J., & Rao, S. N.
- Affiliations
- Trinity Health Grand Rapids (US)
- QIAGEN LLC, Germantown, MD, USA
- Corresponding author
- Dumkow, Lisa E
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-09-01
- Volume
- 76
- Issue
- Supplement_3
- Pages
- iii4-iii11
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- PMC
- PMC8460095
- OpenAlex
- W3201437990
- Cited by
- 57
- References
- 33
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 14 · 2023: 14 · 2022: 3 · 2021: 1
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- QIAGEN Manchester Ltd
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Keywords
- infectious disease diagnosis, antimicrobial resistance, antimicrobial stewardship, clinical microbiology laboratory, laboratory workflow, clinical decision-making, rapid diagnostic tests
- MeSH terms
- Antimicrobial Stewardship, Anti-Infective Agents, Communicable Diseases, Diagnostic Tests, Routine, Patient Care, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.